These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785 [TBL] [Abstract][Full Text] [Related]
5. Future aspects of somatostatin-receptor-mediated therapy. Oberg K Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719 [TBL] [Abstract][Full Text] [Related]
6. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor activation of cellular effector systems. Law SF; Woulfe D; Reisine T Cell Signal; 1995 Jan; 7(1):1-8. PubMed ID: 7538774 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin and its receptor family. Patel YC Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861 [TBL] [Abstract][Full Text] [Related]
9. Internalization-defective mutants of somatostatin receptor subtype 2 exert normal signaling functions in hematopoietic cells. Oomen SP; Hofland LJ; Lamberts SW; Löwenberg B; Touw IP FEBS Lett; 2001 Aug; 503(2-3):163-7. PubMed ID: 11513875 [TBL] [Abstract][Full Text] [Related]
16. Advances in understanding neuronal somatostatin receptors. Selmer I; Schindler M; Allen JP; Humphrey PP; Emson PC Regul Pept; 2000 Jun; 90(1-3):1-18. PubMed ID: 10828487 [TBL] [Abstract][Full Text] [Related]
17. Function and regulation of somatostatin receptor subtypes. Schonbrunn A; Gu YZ; Brown PJ; Loose-Mitchell D Ciba Found Symp; 1995; 190():204-17; discussion 217-21. PubMed ID: 7587648 [TBL] [Abstract][Full Text] [Related]
18. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. Kong H; Raynor K; Yasuda K; Bell GI; Reisine T Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784 [TBL] [Abstract][Full Text] [Related]
19. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
20. [Molecular biology, pharmacology and signal transduction of 5 cloned human somatostatin receptors]. Fehmann HC; Arnold R Z Gastroenterol; 1996 Nov; 34(11):767-74. PubMed ID: 9045539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]